CDC Viral Hepatitis Updates
CDC Foundation’s Summit for the Elimination of Hepatitis B and Hepatitis C as Public Health Threats in the United States (April 27-28, 2017)
The The CDC Foundation and the Viral Hepatitis Action Coalition (VHAC) are convening a Summit April 27-28 in Atlanta, Georgia, to provide the opportunity for diverse stakeholders to come together to discuss the recommendations of the National Strategy for the Elimination of Hepatitis B and C of the National Academies of Science, Engineering and Medicine. The Summit will be open to the public for viewing via a LIVE webcast. (No advance registration is necessary). Information on the Summit, including the latest agenda and information on how to access the LIVE webcast, is now available.
Resources for Hepatitis Awareness Month and Hepatitis Testing Day
The month of May is designated as Hepatitis Awareness Month in the United States, and May 19th is Hepatitis Testing Day. During May, CDC and public health partners work to shed light on this hidden epidemic by raising awareness of viral hepatitis and encouraging priority populations to get tested.
Learn the ABCs of Viral Hepatitis
May is Hepatitis Awareness Month. In the United States, the most common types of viral hepatitis are hepatitis A, hepatitis B, and hepatitis C. While each can produce similar symptoms, each hepatitis virus affects the liver differently, has different routes of transmission, and has different populations that are commonly affected.
Hepatitis Awareness Month Webinar
Join CDC, Hep B United, and NASTAD for a Hepatitis Awareness Month Webinar on April 25th at 1pm EDT/10amPDT. This will be an opportunity to learn about available resources, hear about what partners are doing to promote hepatitis B and hepatitis C testing, and share events you have planned for May.
webinar/register/ cd933fce9c0307b3d746f627e84866 54
Viral Hepatitis and Young Persons Who Inject Drugs
The recent increase in the misuse of opioids and heroin in this country, particularly among persons younger than 40 years of age, has sparked growing public recognition and concern about the negative health effects related to drug use. And deservedly so: hepatitis B virus (HBV) and hepatitis C virus (HCV) are among the numerous health threats facing people who inject drugs (PWID). These blood-borne viral infections have reached epidemic proportions in most states, disproportionately affecting rural communities in addition to young persons. Persons who become infected with HBV and HCV are also at increased risk for other diseases transmitted through injection drug use, including HIV.